MedTrace Logo

Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma

NCT00795782 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 258

Last updated 2016-04-15

No results posted yet for this study

Summary

The purpose of this study is to determine whether the prophylactic ipsilateral central lymph node dissection is equally effective in the management of papillary thyroid microcarcinoma(PTMC) to the bilateral central lymph node dissection.

Conditions

Interventions

PROCEDURE

Prophylactic central lymph node dissection

prophylactic ipsilateral versus bilateral central lymph node dissection

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Han-Sin Jeong, MD, PhD · Samsung Medical Center, Department of Otorhinolaryngology-Head and Neck Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2012-06-30
Completion
2014-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00795782 on ClinicalTrials.gov